Francis Duhay, Director at enVVeno Medical, sold NVNO on Sep 11, 2026
Data as of Oct 27
- Traded
- Sep 11, 2026
- Disclosed
- Sep 14, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NVNO since disclosure
−28.1%
after the sale
Similar stocks (XLV) since disclosure
+6.8%
XLV — its sector index fund
Change in closing price from Sep 14, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.